Australia’s Generic Medicines Industry Association (GMiA) strongly refutes claims by the Consumer Health Forum (CHF) that Australian taxpayers and consumers are over paying for generic medicines by A$2,000 a minute. Comparisons with countries such as the UK and New Zealand do not recognize the significant differences in the way medicines are supplied in Australia.
The fundamental difference is that patients in the UK and NZ receive the generic medicine designated by the state – patients do not have a choice. In Australia, patients are free to choose the original branded medicine and in fact one in four generic drugs dispensed on the Pharmaceutical Benefits Scheme (PBS) are still the original brand, the GMiA argues.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze